Research Analysts Set Expectations for LifePoint Health, Inc.’s Q3 2017 Earnings (NASDAQ:LPNT)
LifePoint Health, Inc. (NASDAQ:LPNT) – Analysts at Oppenheimer Holdings decreased their Q3 2017 earnings estimates for shares of LifePoint Health in a report issued on Tuesday. Oppenheimer Holdings analyst M. Wiederhorn now expects that the company will earn $0.99 per share for the quarter, down from their previous estimate of $1.03. Oppenheimer Holdings also issued estimates for LifePoint Health’s FY2017 earnings at $4.04 EPS, Q1 2018 earnings at $1.07 EPS and Q3 2018 earnings at $1.13 EPS.
LifePoint Health (NASDAQ:LPNT) last announced its quarterly earnings results on Tuesday, August 1st. The company reported $0.96 EPS for the quarter, topping the consensus estimate of $0.90 by $0.06. The business had revenue of $1.59 billion for the quarter, compared to analysts’ expectations of $1.64 billion. LifePoint Health had a net margin of 2.61% and a return on equity of 7.40%. The business’s quarterly revenue was up .2% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.69 EPS.
TRADEMARK VIOLATION NOTICE: This news story was posted by Daily Political and is the sole property of of Daily Political. If you are viewing this news story on another site, it was copied illegally and reposted in violation of United States & international copyright & trademark legislation. The original version of this news story can be viewed at https://www.dailypolitical.com/2017/08/05/research-analysts-set-expectations-for-lifepoint-health-inc-s-q3-2017-earnings-nasdaqlpnt.html.
LPNT has been the topic of several other research reports. BidaskClub upgraded shares of LifePoint Health from a “hold” rating to a “buy” rating in a research report on Friday, June 30th. Zacks Investment Research upgraded shares of LifePoint Health from a “hold” rating to a “buy” rating and set a $73.00 target price on the stock in a research report on Thursday, July 13th. Morgan Stanley started coverage on shares of LifePoint Health in a research report on Tuesday, June 6th. They issued an “equal weight” rating and a $65.00 target price on the stock. Barclays PLC lifted their target price on shares of LifePoint Health from $58.00 to $60.00 and gave the company an “equal weight” rating in a research report on Monday, May 1st. Finally, Leerink Swann upgraded shares of LifePoint Health from a “market perform” rating to an “outperform” rating and lifted their target price for the company from $73.00 to $74.00 in a research report on Tuesday, June 6th. Three research analysts have rated the stock with a sell rating, eight have issued a hold rating and five have issued a buy rating to the company’s stock. LifePoint Health currently has an average rating of “Hold” and an average price target of $66.18.
Shares of LifePoint Health (NASDAQ LPNT) opened at 58.45 on Thursday. LifePoint Health has a 52 week low of $50.60 and a 52 week high of $70.95. The firm has a 50-day moving average of $64.73 and a 200 day moving average of $62.97. The stock has a market cap of $2.34 billion, a PE ratio of 13.09 and a beta of 0.86.
In other LifePoint Health news, Chairman William F. Carpenter III sold 17,653 shares of LifePoint Health stock in a transaction dated Monday, July 17th. The shares were sold at an average price of $65.06, for a total transaction of $1,148,504.18. Following the transaction, the chairman now directly owns 439,841 shares of the company’s stock, valued at $28,616,055.46. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Richard H. Evans sold 2,000 shares of LifePoint Health stock in a transaction dated Thursday, May 11th. The stock was sold at an average price of $62.88, for a total transaction of $125,760.00. Following the transaction, the director now directly owns 17,718 shares in the company, valued at $1,114,107.84. The disclosure for this sale can be found here. Over the last three months, insiders sold 102,000 shares of company stock worth $6,556,824. Insiders own 7.28% of the company’s stock.
A number of institutional investors have recently modified their holdings of LPNT. LS Investment Advisors LLC increased its position in shares of LifePoint Health by 43.7% in the second quarter. LS Investment Advisors LLC now owns 1,785 shares of the company’s stock worth $120,000 after buying an additional 543 shares during the period. US Bancorp DE increased its position in shares of LifePoint Health by 1.6% in the first quarter. US Bancorp DE now owns 1,931 shares of the company’s stock worth $127,000 after buying an additional 30 shares during the period. Bank of Montreal Can increased its position in shares of LifePoint Health by 18.7% in the first quarter. Bank of Montreal Can now owns 1,946 shares of the company’s stock worth $128,000 after buying an additional 306 shares during the period. Teacher Retirement System of Texas purchased a new position in shares of LifePoint Health during the first quarter worth approximately $210,000. Finally, Regent Investment Management LLC purchased a new position in shares of LifePoint Health during the first quarter worth approximately $230,000. 98.75% of the stock is currently owned by institutional investors.
About LifePoint Health
LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.
Receive News & Ratings for LifePoint Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.